Balaji Manohar

Balaji Manohar

Auto-generated profile, based on publicly available information

Balaji Manohar

Department of Periodontology Kalinga Institute of Dental Sciences, KIIT Deemed to be University Bhubaneswar Odisha India

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2015 in Ethiopian Journal of Health Sciences
Verified
Journal Article
Open access
PDF file
Sahar MohsinSahar Mohsin
Sahar Mohsin
BMB Manohar
B Manohar
SRS Rajesh
S Rajesh
YAY Asif
Y Asif
The effects of a dentifrice containing propolis on Mutans streptococci : A clinico-microbiological study

19 January 2024 in Clinical Advances in Periodontics
Verified
Journal Article
Closed access
SSSaravanan SP
Saravanan SP
BMBalaji Manohar
Balaji Manohar

6 January 2025 in Clinical Case Reports
Verified
Journal Article
Open access
MRMANISH RATHI
MANISH RATHI
BMBalaji Manohar
Balaji Manohar
This case report aimed to illustrate the management of single tooth replacement in the esthetic region using immediate implant placement, highlighting the importance of interdisciplinary treatment planning and adherence to esthetic principles. A 37‐year‐old female presented with a fractured upper front tooth, necessitating immediate attention to restore esthetic.

1 January 2025 in Journal of Toxicology
Verified
Journal Article
Open access
DFDelfin Lovelina Francis
Delfin Lovelina Francis
SSSaravanan SP
Saravanan SP
BMBalaji Manohar
Balaji Manohar
SPShaili Pradhan
Shaili Pradhan
Background: Herbal formulations with antimicrobial and anti‐inflammatory properties are commonly used in traditional medicine for oral hygiene. Despite growing popularity, little or no research exists on the safety profile of these products to confirm their long‐term safety. An ayurvedic dentifrice formulation was analyzed in Wistar albino rats for acute and subacute oral toxicity, with emphasis on the toxic effects of the product on physiological, hematological, biochemical, and histopathological parameters. Methods: Wistar rats ( n = 6) were administered a single dose of the test formulation above 2000 mg/kg body weight and were kept on a 14‐day observation period for acute toxicity. Subacute toxicity was induced by daily oral administration of 300, 600, and 1000 mg/kg of the test formulation to male ( n = 30) and female ( n = 30) rats for 28 days. A 14‐day recovery period in the high‐dose group was then carried out. Clinical signs, including mortality, food and water intake, body weight, hematological and biochemical parameters, vital organ weights, and histopathological alterations, were assessed. Results: Acute and subacute toxicity studies did not reveal any mortality or significant clinical signs. At 2000 mg/kg body weight, the hepatic changes were minor and reversible. The no‐observed‐adverse‐effect level (NOAEL) was determined to be 1000 mg/kg body weight, as there were no significant changes in biochemical, hematological, and histopathological parameters until this dose. Conclusions: In Wistar albino rats, the tested Ayurvedic dentifrice formulation tapered with quiescent toxicity can be considered safe for oral use. Long‐term studies in the form of clinical trials are recommended for human use.

27 May 2024 in Medical Journal Armed Forces India
Verified
Journal Article
Closed access
SSSaravanan SP
Saravanan SP
DFDelfin Lovelina Francis
Delfin Lovelina Francis
RHRuchi Harish
Ruchi Harish
KRKumara Raja
Kumara Raja
SKShreehari Ambika Krishnan
Shreehari Ambika Krishnan
KLKesavalu Lakshmyya
Kesavalu Lakshmyya

31 October 2023 in Journal of Oral & Dental Health
Verified
Journal Article
Open access
SSSaravanan Sampoornam
Saravanan Sampoornam
PRPape Reddy
Pape Reddy
LDLovelina Delfin
Lovelina Delfin
SFSaravanan Francis
Saravanan Francis
PSPape Sampoornam
Pape Sampoornam
SCSukhbir Singh Singh Chopra
Sukhbir Singh Singh Chopra
The legislation pertaining to warning labels on tobacco packs exhibit variation across different countries. Numerous countries mandate the inclusion of conspicuous and visually impactful health warnings on cigarette packaging, which serve to depict the detrimental consequences associated with smoking. Typically, these warnings encompass visual representations or textual descriptions illustrating the adverse effects associated with smoking, such as lung cancer, heart disease and other health disorders directly linked to tobacco consumption. Health warnings are frequently governed by regulations that prescribe the dimensions, positioning, and perceptibility of such warnings.